Overview

A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

Status:
Completed

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

A phase Ⅲ, multi-center, randomized, double-blinded, active comparator, factorial design clinical trial to compare the efficacy and safety of a combination therapy of ezetimibe and rosuvastatin versus monotherapy of rosuvastatin in hypercholesterolemia patients.

Phase:

Phase 3

Details

Lead Sponsor:

IlDong Pharmaceutical Co Ltd

Treatments:

Ezetimibe
Rosuvastatin Calcium